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Abstract
 
  Boswellia serrata (Salai Guggal) is one of the most ancient and respected herbs in Ayurveda. 
“Gajabhakshya” a Sanskrit name sometimes used for Boswellia suggests that elephants enjoy 
this herb as a part of their diet. Historically Boswellia serrata is recommended for osteoarthritis, 
juvenile rheumatoid arthritis, soft tissue fibrosis and spondilytis without any side effect. Present 
review focuses on pharmacological activities of Boswellia serrata Roxb.
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Introduction
      Boswellia serrata (Family: Burseraceae) is a deciduous middle sized tree, which is mostly 
concentrated in tropical; parts of Asia and Africa. In India it occurs in dry hilly forests of 
Rajasthan, Madhya Pradesh, Gujarat, Bihar, Assam, Orrisa as well as central penisular regions 
of Andhra Pradesh, Assam etc. The gum is tapped from the incision made on the trunk of the 
tree which is then stored in specially made bamboo basket and converted into different grades 
of material according to flavor, color, shape and size. The fresh gum obtained from the tree is 
hot dry with a pleasant flavor and slightly bitter in taste. It is the ‘frankincense’ of ancient 
Egyptians, Greeks and Romans who used it as prized incense, fumigant as well as a 
multipurpose aromatic. It is generally used in making incense powder and sticks.
        The oleo gum resin of Boswellia serrata is used in various Unani and Ayurvedic 
preparation. It is reported to be useful in the treatment of bronchitis, asthma, cough, bad throat 
and various intestinal problems. It is a diaphoretic and astringent prescribe in various syphilitic 
and pulmonary diseases. It acts as both internal and external stimulant, expectorant, diuretic and 
stomachic. The gum is also prescribed in cases of jaundice, diahhroea, dysentery, dyspepsia and 
hemorrhoids. It is also recommended in weak and unhealthy kind of ulceration (1, 2, 3, 4).
 
Chemistry 
       The essential oil of B. serrata predominantly comprised monoterpenoids, of which -
pinene (73.3%) was the major constituent. Other monoterpenoids identified included -pinene 
(2.05%), cis-verbenol (1.97%), trans-pinocarveol (1.80%), borneol (1.78%), myrcene (1.71%), 
verbenone (1.71%), limonene (1.42%), thuja-2,4(10)-diene (1.18%) and p-cymene (1.0%), 
while -copaene (0.13%) was the only sesquiterpene identified in the oil.(8). Higher terpenoids 
constitute the major fraction (25-35 %) of the oleo-gum-resin. The first terpenoids isolated is 
boswellic acid in1898 by Tschirh et al (5).  Since then a number of chemists have worked on 
the structural elucidation of boswellic acid. Structure of methyl ester of acetyl- β -boswellic 
acid has also been confirmed by single crystal X-ray studies recently (6). 
       Besides boswellic acid several other triterpenoids have also been isolated from the gum 
resin, these, compounds include α -amyrins, 11-keto-a-boswellic acid, 3’ hydroxyl urs-9, 11 – 
dien-24-oic acid, 3’-acetoxy urs-9, 11-dien-24-oic- acid (Fig. I). Tetracyclic triterpenoic acids 
have, also been reported by Pardhy et. al., these compounds are 3’- hydroxyl-tirucall-8, 24-dien-
21-oic acid 3’- hydroxyl-tirucall-8, 24-dien-21-oic acid, 3-keto-tirucall-8, 24-dien-21-oic acid 
3’-hydroxy-tirucall-8, 24-dien-21-oic acid 3-keto-tirucall-8, 24-dien-21-oic acid, and 3’- 
acetoxy tirucall-8, 24-dien-21-oic acid (Fig.2) Besides, these authors have also reported the 
isolation of a new diterpene alcohol serratol (7). 
 
 
 
 
 
 
 
              Fig. 1. Structures of different boswellic acids.
 
 
Pharmacological Activities
Anti-inflammatory Activity on New Papaya Latex Model 
       The Boswellic acid from B. serrata when tested  on new model i.e Papaya Latex Model, 
showed significant activity of mean 35% inhibition of inflammation. Since the new model is 
reported to be sensitive to slowly acting, remission inducing drugs. Its effectiveness on 
boswellic acid throws some light on its mechanism of action which seems to be unlike aspirin 
and steroidal drugs (9). 
 
Leukotriene Inhibition
       Ethanol extract of the gum resin inhibits the formation of Leukotriene B4 in rat peritoneal 
neurophils. Leukotriene such as LTB4 is recognized as one of the important mediators of 
inflammatory reactions. Leukotrienes are synthesized by stimulated phagocytes cells, 
particularly the neutrophills. The production of chemostatic factors by these cells attracts more 
phagocytes to sites of inflammation. Most other non-steroidal anti-inflammatory drugs act 
through the inhibition of prostaglandins produced by stimulated phagocytes. Boswellic acid, 
therefore, is different from other known non-steroidal anti-inflammatory drugs in its mode of 
action and relatively free from side effects (10). 
Analgesic and Psychopharmacological effects 
       Menon et al, revealed that the gum resin of B. serrata possess marked analgesic activity in 
experimental animals in addition to its sedative effect. They have found that it produces 
reduction in the spontaneous motor activity and caused plosis in rats (11).
Anti inflammatory and Anti-arthritic activity’s (12)
        Extract of salai guggal caused inhibition of the Carrageenan induced rat hind paw oedema 
by 39.75% and 65-73%, administered orally (p.o.) in dose ranges of 50-200 mg per kg -1 and 
interaperitoneal (i.p.) in does rang of 50-100 mg per kg-1 respectively compared to 47% 
inhibition seen with phenylbutazone (50mg/kg -1 p.o.). In the anti-arthritic study on the 
mycobacterium adjuvant-induced poly-arthritic in rats, salai guggal showed 34% and 49% 
inhibition of paw swelling with 50 and 100 mg per kg -1 (p.o.) doses respectively as compared 
to controls. 
       Singh et al (13) studied the anti-inflammatory activity of mixture of Boswellic acid 
(Composed of 5 acids with a-Boswellic acid as the major component). This showed 25-46% 
inhibition of paw oedema in rats and mice. In chronic test of formaldehyde arthritis it exhibited 
45-67% antiarthritic activity in a similar dose range. The fraction was effective in both adjuvant 
arthritis (35-59%) as well as established arthritis (54-84%) It also showed antipyretic effect, 
with no ulcerogenic effect and well tolerated in as high a dose as 2 gm/kg p.o, mice.
Effects on leucocytes migration 
       Ammon, et al, (14) carried out studies on leukocytes migration into the inflammatory 
exudates caused by Carrageenan. It was found to exert marked inhibitory effect on both the 
volume and leucocytes population of pleural exudates. In acute test model of Carrageenan 
induced pleurisy in rats. Extract of salai guggal in a dose of 100 mg per kg orally showed 
significant reduction of pleural exudates volume (47.93%): P<0.001) and leucocytes population 
(26.42% P <0.001). The effects on these parameters were more pronounced when animals were 
treated with Extract of salai guggal in a dose of 100 mg per kg p.o. for 10 days before the test 
performance. 
Immunomodulatory activity 
       Extract of gum resin of B. serrata containing 60% acetyl 11-keto beta boswellic acid 
(AKBA) along with other constituents such as 11-keto beta-boswellic acid (KBA), acetyl beta-
boswellic acid and beta-boswellic acid has been evaluated for antianaphylactic and mast cell 
stabilizing activity using passive paw anaphylaxis and compound 48/80 induced degranulation 
of mast cell methods. The extract inhibited the passive paw anaphylaxis reaction in rats in dose-
dependant manner. However, the standard dexamethasone (0.27 mg/kg, p.o) revealed maximum 
inhibition of edema as compared to the extract. A significant inhibition in the compound 48/80 
induced degranulation of mast cells in dose-dependant manner was observed thus showing mast 
cell stabilizing activity. The standard disodium cromoglycate (50 mg/kg, ip) was found to 
demonstrate maximum per cent protection against degranulation as compared to the extract 
containing 60% AKBA (15). 
Anticancer Activity
        Alcoholic extract of salai guggal (AESG) for anti-carcinogenicity in mice with ehrlic 
ascites carcinoma and S-180 tumor, found inhibition of tumor growth by inhibiting cell 
proliferation and cell growth due to the interference with biosynthesis of DNA, RNA and 
proteins (16). Topical application of Boswellin with 5 nmol TPA twice daily for 16 weeks to 
mice previously treated with dimethylbenz-anthracene caused 87- 99% inhibition in the number 
of tumor (17). Boswellic acids induce concentration dependent inhibition of glioma cell 
proliferation and show anti-edema effect in glioblastoma patients (18). It was also revealed that 
Boswellic acids induced apoptosis is protein synthesis dependent and not associated with free 
radical scavenging activity. 
Hypolipidemic and Hepatoprotective activity
        Water soluble fraction of B. serrata extract decreased total cholesterol (38-48%) and 
increased HDL in rats fed on atherogenic diet, thus proving its hypolipidemic potential (19). 
alcoholic extract of salai guggal (AESG) causes hepatoprotection in galactosamine/endotoxin 
induced liver damage in mice which was reflected by reduced titre of SGOT, SGPT, 
aminotransferase and serum enzymes (20). 
Hypoglycemic Activity
       Herbal formulation containing B. serrata oleo-gum-resin as one of the ingredients has been 
reported to produce significant anti-diabetic activity on non-insulin dependent diabetes mellitus 
in streptozocin induced diabetic rat model where reduction in blood-glucose level was 
comparable to that of phenformin (21). 
Antidiarrhoeal
      Boswellia serrata extract (BSE) was found effective in treating diarrhoea in patient with 
inflammatory bowel syndrome without causing constipation. It was also found effective against 
acetylcholine and barium chloride induced diarrhoea by inhibiting contraction of intestinal 
smooth muscles. The extract also inhibited gastrointestinal transit in croton and castor oil 
induced diarrhoea in mice. However, intestinal motility remained unaffected in control mice by 
BSE (22). 
Antimicrobial activity 
       Essential oil from the bark of B.serrata was tested against Gram positive and Gram negative 
bacteria. The essential oil exhibited significant inhibitory activity against S.aureus OGSUTH 
108, E.coli LASUTH 54 and Proteus mirabilis UCH 28 (24). 
Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase
 
        BA and derivatives concentration dependently decreased the formation of leukotriene B4 
from endogenous arachidonic acid in rat peritoneal neutrophils. Among the BAs, acetyl-11-keto-
beta-BA induced the most pronounced inhibition of 5-lipoxygenase (5-LO). It did not impair 
the cyclooxygenase and 12-lipoxygenase in isolated human platelets and the peroxidation of 
arachidonic acid by Fe-ascorbate (25).
Clinical Evaluation 
        Kimmatkar, N., et al, A randomized double blind placebo controlled crossover study was 
conducted to assess the efficacy, safety and tolerability of Boswellia serrata Extract (BSE) in 30 
patients of osteoarthritis of knee, 15 each receiving active drug or placebo for eight weeks. 
After the first intervention, washout was given and then the groups were crossed over to receive 
the opposite intervention for eight weeks. All patients receiving drug treatment reported 
decrease in knee pain, increased knee flexion and increased walking distance (26).
Anti-asthmatic activity
      In a double blind placebo control clinical study with 300mg thrice daily dose for 6 weeks, 
Gupta et al (1998) established anti-asthmatic potential of alcohol extract of salai guggal 
(AESG) where 70% of the patients with prolong history of asthma showed improvement in 
physical symptom and sign of dyspnoea, bronchi, number of attacks, increase in stimulation of 
mitogen activated protein kinase MAPK and mobilization of intracellular Ca2+ (23)
Chronic Toxicity Studies
        Atal, et al. (1982), conducted chronic toxicity studies in 16 normal healthy monkeys 
divided in four groups. Each group comprised of two, weight was recorded before and at 
monthly intervals after drug administration. Haematological and biochemical estimations were 
done prior to drug administration and monthly intervals after drug administration. 
Haematological and biochemical estimations were done prior to drug administration and at 
monthly intervals after drug treatment. DAESG was administered orally in three dose levels to 
three groups i.e., low dose of 2 X ED50, medium does of 5 X ED50, for six moths and one 
group served as a control. All the animals were maintained under uniform husbandry condition 
throughout the experiment. Biochemical hematological, histopathological, and other 
observations revealed no toxicity. 
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